Business
Katherine M. Prioli, MS, Laura T. Pizzi, PharmD, MPH, Kathryn M. Kash, PhD, Andrew B. Newberg, MD, Anna Marie Morlino, PharmD, Michael Matthews, BS, Daniel A. Monti, MD
Katherine M. Prioli, BS; Laura T. Pizzi, PharmD, MPH; Kathryn M. Kash, PhD; Andrew B. Newberg, MD;
Anna Marie Morlino, PharmD; Michael J. Matthews, BS; Daniel A. Monti, MD
Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care
Linda Bily, MA, CSA, OPN-CG
Suela Sulo, PhD, MSc, Josh Feldstein, BA, Jamie Partridge, PhD, MBA, Bjoern Schwander, MA, RN, Krishnan Sriram, MD, Wm. Thomas Summerfelt, PhD
Suela Sulo, PhD; Josh Feldstein, BA; Jamie Partridge, PhD, MBA; Bjoern Schwander, MS, RN; Krishnan
Sriram, MD; Wm. Thomas Summerfelt, PhD
The Crucial Role of Nutrition Support Services for Hospitalized Patients
Jack E. Fincham, PhD, RPh
Mark Slomiany, PhD, MBA, MPA; Priya Madhavan; Michael Kuehn; Sasha Richardson, MBA
Payers’ Utilization of Value Frameworks Tools in Their Drug Coverage Decision-Making
Matthew Mitchell, PharmD, MBA, FAMCP
Kathryn Fitch, RN, MEd; J. Michael Woolley, PhD; Tyler Engel, ASA, MAAA; Helen Blumen, MD, MBA
Hyperkalemia in Chronic Diseases: A Serious Medical Condition in Need of Clinical Guidelines and New Treatment Options
Quang T. Nguyen, DO, FACP, FACE, FTOS
Uche Anadu Ndefo, PharmD, BCPS; Rolicia Norman, PharmD; Andrea Henry, PharmD, MBA
The Benefits of and Needs for Academic Detailing
Jack E. Fincham, PhD, RPh
Bettina M. Beech, DrPH, MPH, Tristan Cordier, MPH, Laura E. Happe, PharmD, MPH, Laura Trunk, MD, Gilbert S. Haugh, MS, Richard Kwong, MPH, Vipin Gopal, PhD, Roy A. Beveridge, MD
Bettina M. Beech, DrPH, MPH; Tristan Cordier, MPH; Laura E. Happe, PharmD, MPH; Laura Trunk, MD;
Gilbert S. Haugh, MS; Richard Kwong, MPH; Vipin Gopal, PhD; Roy A. Beveridge, MD
Patients’ Choice for Site of Care Motivated by More Than Cost Alone
James T. Kenney, Jr, RPh, MBA
Kumar Mukherjee, PhD; Khalid M. Kamal, PhD
Understanding Patients’ Demographics Is Key to Improving Clinical and Economic Healthcare Outcomes
F. Randy Vogenberg, RPh, PhD
Christopher B. Atzinger, MS, PhD candidate; Jeff J. Guo, BPharm, PhD
Rheumatoid Arthritis, Biologic Drugs, and Associated Cost
Byron C. Scott, MD, MBA
Joseph Lee, PhD, Ryan Pelkey, MS, Julieanna Gubitosa, BS, Michael F. Henrick, MBA, Michael L. Ganz, PhD
Joseph Lee, PhD; Ryan Pelkey, MS; Julieanna Gubitosa, BS; Michael F. Henrick, MBA;
Michael L. Ganz, MS, PhD
Identifying the Most Clinically and Economically Effective Therapies for Rheumatoid Arthritis Remains a Challenge for Providers and Payers
Gary Branning, MBA
Thanh-Nghia Nguyen, DrPH, MPH, MBA, Jeffrey Trocio, MPH, Stacey Kowal, MS, Cheryl P. Ferrufino, Julie Munakata, MS, Dell South, PharmD
Hypothesis Generation: An Essential Component of Informed Healthcare Management